Glenmark Pharmaceuticals is currently trading at Rs. 643.80, up by 4.55 points or 0.71% from its previous closing of Rs. 639.25 on the BSE.

The scrip opened at Rs. 640.10 and has touched a high and low of Rs. 647.05 and Rs. 625.65 respectively. So far 77802 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 658.00 on 14-Jun-2021 and a 52 week low of Rs. 398.70 on 18-Jun-2020.

Last one week high and low of the scrip stood at Rs. 658.00 and Rs. 625.65 respectively. The current market cap of the company is Rs. 18157.52 crore.

The promoters holding in the company stood at 46.63%, while Institutions and Non-Institutions held 35.00% and 18.38% respectively.

Glenmark Pharmaceuticals has launched bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name - Tiogiva, in UK for the treatment of chronic obstructive pulmonary disease (COPD). COPD is a long-term condition that causes inflammation in the lungs, damaged lung tissue and a narrowing of the airways, making breathing difficult.

There are many different types of the condition, although little is known about what causes this variation and the best way to manage the different versions of the disease. According to data from IQVIA, Tiotropium DPI had a market size of $450 Million in the EU in the 12 month period ended September 2020.

Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries.

Glenmark Pharma Share Price

1946.10 -19.95 (-1.01%)
17-Dec-2025 14:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.90
Dr. Reddys Lab 1272.30
Cipla 1495.50
Zydus Lifesciences 917.85
Lupin 2111.20
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×